All stock lists
Gyre Therapeutics, Inc. (NASDAQ:GYRE)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
4.28-0.37 (-7.97%)
Market cap
$454M
Insider Score
Health Score
Analyst consensus
Listed since
Apr 12, 2006
Website
Insider Score
––Not scored
GYRE Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Corporate Lobbying
Government lobbying spending instances
Loading filings…
Source: U.S. Senate LDA
Corporate Lobbying
GYRE Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New GYRE patent grants
Loading patent grants…
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to GYRE from public contracts
Source: USAspending.gov
Recently reported changes in GYRE holdings by institutional investors
Scanning latest 13F filings…
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Congressional Trades
U.S. House and Senate disclosures referencing GYRE, reported under the STOCK Act.
| Politician | Chamber | Action | Amount | Date |
|---|---|---|---|---|
| No congressional trades recorded for GYRE. | ||||
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.